In a landmark study published in the journal Nature Communications on January 2, 2025, a research team led by Professor…
Read More

In a landmark study published in the journal Nature Communications on January 2, 2025, a research team led by Professor…
Read More
The pursuit of commercial nuclear fusion has long been described as the "holy grail" of clean energy, promising a nearly…
Read More
The rise of glucagon-like peptide-1 (GLP-1) receptor agonists has fundamentally altered the landscape of metabolic medicine in the United States.…
Read More
The pursuit of clean, virtually limitless energy through nuclear fusion has long been hampered by the volatile nature of plasma,…
Read More
As the prevalence of glucagon-like peptide-1 (GLP-1) receptor agonists continues to reshape the landscape of metabolic health in the United…
Read More
For decades, the pursuit of controlled nuclear fusion has been described as the ultimate "holy grail" of energy production—a promise…
Read More